Company Analysis
Sign in

IGC Pharma, Inc. (IGC)

NYSE: IGC · Pharmaceutical Preparations · Potomac, MD · filing with the SEC since 2005
Full chart Alerts Compare
Grade5.0
◀ Past 4.0● Present 6.2▶ Future 4.7
3 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

7 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to IGC Pharma, Inc.’s names, not what it holds today.

Patents granted
7
7 utility, 1976 to Dec 31, 2025
Granted in 2025
2
in the last year the record reads
Applications published
14
1 of them in 2025
Names they are printed under
3
a former name, its holding company
By yearGrantedApplications published
'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals4
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name3 counted
India Globalization Capital, Inc. a former name
US, as the owner printed on each patent
5 granted
12 published
IGC Pharma IP, LLC its holding company
US, as the owner printed on each patent; a holding company under the name IGC Pharma, Inc.
2 granted
1 published
India Globalization Capital, Inc. a former name
named as the applicant on its applications, in US
0 granted
1 published
Names not counted (1)
SAN Holdings, LLC
Most of its patents print JP; this name counts in US. 2 granted and 0 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 9, 202512,491,200Compositions and methods using cannabinoids for treating stammering/stuttering and symptoms of Tourette syndromePharmaceuticalsIGC Pharma IP, LLC
Nov 11, 202512,465,589Method and composition for treating CNS disordersPharmaceuticalsIGC Pharma IP, LLC
Jun 7, 202211,351,152Method and composition for treating seizure disordersPharmaceuticalsIndia Globalization Capital, Inc.
Mar 2, 202110,933,082Cannabinoid composition and method for treating painPharmaceuticalsIndia Globalization Capital, Inc.
Aug 25, 202010,751,300Composition and method for treating seizure disordersPharmaceuticalsIndia Globalization Capital, Inc.
Mar 24, 202010,596,159Method and composition for treating cachexia and eating disordersPharmaceuticalsIndia Globalization Capital, Inc.
Nov 6, 201810,117,891Cannabinoid composition for treating painPharmaceuticalsIndia Globalization Capital, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Sep 4, 20252025/0275935COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH DEMENTIA DUE TO ALZHEIMER'S DISEASE WITH A COMBINATION OF THC AND MELATONINPharmaceuticalsIGC Pharma IP, LLC
Jan 11, 20242024/0009207CANNABIDIOL (CBD) BASED COMPOSITION AND METHOD FOR TREATING PAINPharmaceuticalsIndia Globalization Capital, Inc.
Aug 10, 20232023/0248697METHOD AND COMPOSITION FOR TREATING CNS DISORDERSPharmaceuticalsIndia Globalization Capital, Inc. · patent 12,465,589 granted from it
Aug 18, 20222022/0257560COMPOSITIONS AND METHODS USING CANNABINOIDS FOR TREATING STAMMERING/STUTTERING AND SYMPTOMS OF TOURETTE SYNDROMEPharmaceuticalsIndia Globalization Capital, Inc. · patent 12,491,200 granted from it
Aug 4, 20222022/0241244Method and Composition for Treating Seizure DisordersPharmaceuticalsIndia Globalization Capital, Inc.
Nov 18, 20212021/0353705METHOD AND COMPOSITION FOR RELIEVING FATIGUE AND RESTORING ENERGYPharmaceuticalsIndia Globalization Capital, Inc.
Jan 28, 20212021/0023053METHOD AND COMPOSITION FOR TREATING CNS DISORDERSPharmaceuticalsIndia Globalization Capital, Inc.
Dec 10, 20202020/0383935COMPOSITION FOR TREATING SEIZURE DISORDERSPharmaceuticalsIndia Globalization Capital, Inc.
Jun 11, 20202020/0179342Method and Composition for Treating Seizure DisordersPharmaceuticalsIndia Globalization Capital, Inc. · patent 11,351,152 granted from it
Feb 13, 20202020/0046722METHOD AND COMPOSITION FOR TREATING EATING DISORDERSPharmaceuticalsIndia Globalization Capital, Inc.
What it applied for, 2024 to 2025: Pharmaceuticals 2.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton IGC · research, not advice